Japan plans to revise its guidelines on the drone delivery of medicines later this month, which would mark the first revision since they were established two years ago. Service providers are closely watching how they will be revised, with calls…
HOME > TOP STORIES
TOP STORIES
-
REGULATORY Rule Review in Similar Drug Re-Pricing Yields 50 Exemptions Based on Competitiveness
January 26, 2012
-
REGULATORY 16 APIs Including Aricept, Lyrica to Be Re-Priced for Market Expansion
January 25, 2012
-
BUSINESS Mochida President Hopes to Ease Impact of Next NHI Price Revision with New Drugs
January 24, 2012
-
BUSINESS Growell President Takada Says Ready for Legal Action on Stoppage of “Dispensing Point” System
January 23, 2012
-
REGULATORY PMDA to Introduce Direct ADR Reporting System for Patients on Trial Basis
January 20, 2012
-
BUSINESS Takeda President Hasegawa Envisions Japanese National as Successor
January 19, 2012
-
BUSINESS Nexium Dominates Top 2 Rankings in HP Market 2 Months in a Row: RepTrack Dec. Survey
January 18, 2012
-
ORGANIZATION JPWA, NPhA Hold Talks for Distribution Improvement
January 18, 2012
-
REGULATORY US Industry Opinion Divided on Japan’s Participation in TPP Talks
January 17, 2012
-
REGULATORY MHLW Proposes New Fee for Medical Management of Treatment-Resistant Schizophrenia
January 16, 2012
-
ORGANIZATION JGA President Sawai Says Members United to Provide Stable Drug Supplies to Meet Boosted Demand
January 13, 2012
-
ORGANIZATION JPWA President Bessho Expresses Resolve for Distribution Improvement
January 12, 2012
-
BUSINESS Kyowa Hakko Kirin to Develop Expert MRs to Boost Cancer Field
January 11, 2012
-
BUSINESS Bayer Yakuhin President Guth Says Marketing Success of 2 Strategic Products Key Focus
January 10, 2012
-
BUSINESS AZ to Utilize E-detailing, Optimize According to Product
January 6, 2012
-
ORGANIZATION FPMAJ Chairman Pledges Further Efforts for Permanent Introduction of Premium, Caution Towards Additional Price Cuts Becoming Rule
January 5, 2012
-
ORGANIZATION New Year’s Message: On behalf of the JPMA, I would like to express our best wishes for a Happy New Year as we see the start of 2012.
January 5, 2012
-
BUSINESS Aricept Overtakes Blopress to Take Top Spot in Domestic Drug Sales
December 28, 2011
-
REGULATORY Additional NHI Price Cuts Decided: ¥22.5 Billion for Long-Listed Drugs, ¥2.5 Billion for Generics
December 27, 2011
-
REGULATORY PFSB Draft Budget Includes ¥2.1 Bil. to Improve Review, Safety Measures
December 27, 2011
ページ
The healthcare supply chain in Japan, as in all major markets, consists of biopharmaceutical manufacturers selling to wholesalers who in turn sell to hospitals, clinics, and pharmacies, where the drugs are finally dispensed to patients. Each party ideally contributes value…
The health ministry’s key expert panel on February 15 agreed on the need to consolidate the Japanese generic sector to…
A key Japanese reimbursement policy panel on December 16 approved the government-backed plan for the FY2023 “off-year” drug price revision.…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…